X-Ventures said it had acquired a 26% stake in eMMUNITY with the investment. Elemér Piros, eMMUNITY managing director, said the company’s technology facilitates the creation of an anti-cancer vaccine tailored to an individual patient’s immune system.

X-Ventures has made eleven investments totalling almost 3 billion forints since it was established in 2010 with the support of the European Union’s Jeremie initiative, under which EU structural funds can be used to finance SMEs.

Source www.hungarymatters.hu

Follow that link to sign-up for MTI’s twice-daily newsletter.